CAD Sciences' software has the only products on the market with a TRM module that facilitates monitoring of vascular permeability over time, considered a key early physiological indicator of cancer, in lesions treated with radiation, hormonal or chemo therapy. The latest product release contains a new TRM module that assists those radiologists wishing to monitor, over time, a patient's response to cancer therapy. TRM is used by radiologists to compare, on a quantitative basis, changes in vascular permeability that are obtained at various stages in a patient's cancer therapy treatment and measured by the Server2.4's advanced fTP algorithm.
Andreas Muehler, President of CAD Sciences, commented: "TRM represents a significant advance in the radiologist's ability to monitor, via a very early response indicator, whether cancer therapy is working. Such response is measurable long before current radiological methods that are principally dependent on the measurement of tumour size on CT. In the future, it may allow patients to be directed to the most effective therapies, thereby avoiding the unnecessary side effects of less-effective therapies."
This capability permits the radiologist user to identify lesions and generate diagnosis reports with graphical and quantitative analysis of tissue biology. These reports include numerical measurements of vascular permeability and cellular density, as well as standard contrast wash-in and wash-out measurements. Statistical analysis of the lesion may be performed in 2D or 3D based on user preference. This advanced capability has been integrated into an advanced work flow roadmap regime that guides the radiologist through the series of sequential tasks that must be performed in order to arrive at a diagnosis.
WorkSpace has been configured to permit image viewing in dual, triple or super-wide monitor settings. Until now, the company offered only single monitor viewing of its advanced fTP imagery. Henry Wyszomierski, CTO of CAD Sciences, explained the context of this improvement: "While we offered the industry's most advanced pharmacokinetic analysis, the visualization component of our product was somewhat limited by the use of a single monitor. The ability to offer multiple monitor configurations to customers is more consistent with our leadership position in pharmacokinetic analysis."
With Workspace2.1, users may now create multiple customized reporting templates for referring physicians according to specific information content or presentation format preferences. Individual reports can now be prepared using WorkSpace's drag-and-drop image panes that allow for placement and final optimization of image screenshots, graphs and histogram data. For the first time, image panning, zooming, and cropping may now be performed directly inside the report. The end result is a better presentation of a radiologist's findings to his referral base.
A new hanging protocol system allows users to create and save preferred viewing configurations in WorkSpace. MR images and supporting graphical or statistical analysis cards may now be pre-programmed at system installation, thereby permitting the radiologist to call up images according to a preferred hanging protocol. This new capability has eliminated the need to reconfigure image presentation for each individual use.
Aside from a clean new look and feel, WorkSpace and Server2 facilitate image compression for seamless transfer across networks. From a product service perspective, the new software facilitates the remote performance of system diagnostics, maintenance and upgrades.
Founded in March 2002, CAD Sciences is a technology expert in the advancement of computer-assisted modelling of contrast enhancement in MR imaging of cancer. From its base in White Plains, New York, the company designs and internationally distributes certain intellectual property in Computer Assisted Diagnosis (CAD) and Magnetic Resonance Angiography (MRA) software for medical imaging. The company's Server2 and WorkSpace software platforms are currently used by radiologist customers to facilitate the analysis, interventional planning and reporting of breast and prostate MRI.
Together these products automate MRI image processing and provide higher quality imaging studies, lower facility costs, increased revenue streams for radiology practices as well as improved analysis and reporting tools for physicians. In addition, the company is the sole distributor of Machnet breast biopsy intervention devices and magnetic resonance breast and carotid coils.